Etoxazole; Pesticide Tolerances, 25156-25161 [E9-12292]
Download as PDF
25156
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
substantial number of small entities
under the Regulatory Flexibility Act (5
U.S.C. 601 et seq.);
• Does not contain any unfunded
mandate or significantly or uniquely
affect small governments, as described
in the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4);
• Does not have Federalism
implications as specified in Executive
Order 13132 (64 FR 43255, August 10,
1999);
• Is not an economically significant
regulatory action based on health or
safety risks subject to Executive Order
13045 (62 FR 19885, April 23, 1997);
• Is not a significant regulatory action
subject to Executive Order 13211 (66 FR
28355, May 22, 2001);
• Is not subject to requirements of
Section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (15 U.S.C. 272 note) because
application of those requirements would
be inconsistent with the CAA; and
• Does not provide EPA with the
discretionary authority to address, as
appropriate, disproportionate human
health or environmental effects, using
practicable and legally permissible
methods, under Executive Order 12898
(59 FR 7629, February 16, 1994).
In addition, this rule does not have
tribal implications as specified by
Executive Order 13175 (59 FR 22951,
November 9, 2000), because the SIP is
not approved to apply in Indian country
located in the state, and EPA notes that
it will not impose substantial direct
costs on tribal governments or preempt
tribal law.
List of Subjects in 40 CFR Part 52
Environmental protection, Air
pollution control, Incorporation by
Reference, Intergovernmental relations,
Ozone.
Dated: May 14, 2009.
Jane Diamond,
Acting Regional Administrator, Region IX.
Part 52, chapter I, title 40 of the Code
of Federal Regulations is amended as
follows:
■
PART 52—[AMENDED]
1. The authority citation for part 52
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
PWALKER on PROD1PC71 with RULES
Subpart F—California
2. A new § 52.282 is added to read as
follows:
■
§ 52.282
Ozone.
Control strategy and regulations:
(a) Attainment determination. EPA
has determined that the Ventura County
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
severe 1-hour ozone nonattainment area
attained the 1-hour ozone NAAQS by
the applicable attainment date of
November 15, 2005. EPA also has
determined that the Ventura County
severe 1-hour ozone nonattainment area
is not subject to the requirements of
section 185 of the Clean Air Act (CAA)
for the 1-hour standard and that the
State is not required to submit a SIP
under Section 182(d)(3) of the CAA to
implement a section 185 program for the
1-hour standard in this area. In addition,
the requirements of section 172(c)(9)
(contingency measures) for the 1-hour
standard do not apply to the area.
(b) [Reserved]
[FR Doc. E9–12135 Filed 5–26–09; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2008–0554; FRL–8413–5]
Etoxazole; Pesticide Tolerances
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Final rule.
SUMMARY: This regulation establishes
tolerances for residues of etoxazole in or
on stone fruit; plum; prune; spearmint
tops and oil; peppermint tops and oil;
tomato; and cucumber. This regulation
also deletes the existing cherry
tolerance, as it will be superseded by
inclusion in the stone fruit crop group.
The Interregional Research Project
Number 4 (IR-4) requested these
tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective May
27, 2009. Objections and requests for
hearings must be received on or before
July 27, 2009, and must be filed in
accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
ADDRESSES: EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2008–0554. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Laura Nollen, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(703) 305–7390; e-mail address:
nollen.laura@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to those engaged in the
following activities:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
This listing is not intended to be
exhaustive, but rather to provide a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies
of this Document?
In addition to accessing electronically
available documents at https://
www.regulations.gov, you may access
this Federal Register document
electronically through the EPA Internet
under the ‘‘Federal Register’’ listings at
https://www.epa.gov/fedrgstr. You may
also access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
cite at https://www.gpoaccess.gov/ecfr.
E:\FR\FM\27MYR1.SGM
27MYR1
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
C. Can I File an Objection or Hearing
Request?
Under section 408(g) of FFDCA, 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2008–0554 in the subject line on
the first page of your submission. All
requests must be in writing, and must be
mailed or delivered to the Hearing Clerk
as required by 40 CFR part 178 on or
before July 27, 2009.
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket that is described in
ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit this copy,
identified by docket ID number EPA–
HQ–OPP–2008–0554, by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
PWALKER on PROD1PC71 with RULES
II. Petition for Tolerance
In the Federal Register of August 13,
2008 (73 FR 47186) (FRL–8375–8), EPA
issued a notice pursuant to section
408(d)(3) of FFDCA, 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP 8E7347) by IR-4,
Rutgers, The State University of New
Jersey, 500 College Road East, Suite 201
W., Princeton, NJ 08540. The petition
requested that 40 CFR 180.593 be
amended by establishing tolerances for
residues of the insecticide etoxazole, 2(2,6-difluorophenyl)-4-[4-(1,1dimethylethyl)-2-ethoxyphenyl]-4,5-
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
dihydrooxazole, in or on fruit, stone,
group 12, except plum at 1.0 parts per
million (ppm); plum at 0.12 ppm; plum,
prune, dried at 0.4 ppm; cucumber at
0.02 ppm; tomato at 0.25; spearmint,
tops at 10 ppm; peppermint, tops at 10
ppm; peppermint, oil at 20 ppm; and
spearmint, oil at 20 ppm. The petition
additionally requested to delete the
tolerance for residues of etoxazole in or
on the food commodity cherry at 1.0
ppm. That notice referenced a summary
of the petition prepared on behalf of IR4 by Valent U.S.A. Corporation, the
registrant, which is available to the
public in the docket, https://
www.regulations.gov. Comments were
received on the notice of filing. EPA’s
response to these comments is
discussed in Unit IV.C.
Based upon review of the data
supporting the petition, EPA has revised
the proposed tolerance levels for plum;
plum, prune, dried; and tomato. The
reason for these changes is explained in
Unit IV.D.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with section 408(b)(2)(D)
of FFDCA, and the factors specified in
section 408(b)(2)(D) of FFDCA, EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for the petitioned-for
tolerances for residues of etoxazole on
fruit, stone, group 12, except plum at 1.0
ppm; plum at 0.15 ppm; plum, prune,
dried at 0.30 ppm; cucumber at 0.02
ppm; tomato at 0.20; spearmint, tops at
10 ppm; peppermint, tops at 10 ppm;
PO 00000
Frm 00013
Fmt 4700
Sfmt 4700
25157
peppermint, oil at 20 ppm; and
spearmint, oil at 20 ppm. EPA’s
assessment of exposures and risks
associated with establishing tolerances
follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
The existing etoxazole data indicate
that it possess low acute toxicity via all
routes of exposure. It is not an eye or
dermal irritant or a dermal sensitizer.
No toxicity was seen at the limit dose
in a 28–day dermal toxicity study in
rats.
The liver is the main target organ in
mice, rats and dogs. In a 90–day toxicity
study in dogs, increased liver weights
and centrilobular hepatocellular
swelling in the liver were observed.
Similar effects were observed in a
chronic toxicity study in dogs at similar
doses, indicating that systemic effects
(mainly liver effects) occur at similar
dose levels following short- through
long-term exposure without increasing
in severity. In a 90–day toxicity study in
mice, hepatotoxicity (increased relative
liver weight, liver enlargement, and
centrilobular hepatocellular swelling)
was observed at high doses. Similar
effects were observed at the high dose
in a mouse carcinogenicity study.
Subchronic and chronic toxicity studies
in rats produced similar effects
(increased liver weights, centrilobular
hepatocellular swelling, etc.) to those
seen in mice and dogs. In addition,
slight increases in thyroid weights and
incisors were observed in subchronic
and chronic toxicity studies in rats at
high doses and at terminal stages of the
study. Toxicity was not observed at the
highest dose tested (HDT) in another
carcinogenicity study in mice. There is
no evidence of immunotoxicity or
neurotoxicity in any of the submitted
studies.
Two studies in mice showed no
evidence of carcinogenicity up to the
HDT. In a rat carcinogenicity study,
which was deemed unacceptable due to
inadequate dosing, benign interstitial
cell tumors (testis) and pancreas benign
islet cell adenomas were observed (in
females) at the high dose. These effects
were not observed in an acceptable
carcinogenicity study in rats at higher
doses. In special mechanistic male rat
studies there were no observable
E:\FR\FM\27MYR1.SGM
27MYR1
25158
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
PWALKER on PROD1PC71 with RULES
changes in serum hormone levels
(estradiol, luteinizing hormone (LH),
prolactin and testosterone) or
reproductive effects (interstitial cell
proliferation or spermatogenesis) noted.
EPA classified etoxazole as ‘‘not likely
to be carcinogenic to humans.’’
Etoxazole is not mutagenic.
The toxicology data for etoxazole
provides no indication of increased
susceptibility, as compared to adults, of
rat and rabbit fetuses to in utero
exposure in developmental studies. The
rabbit developmental toxicity study
included maternal toxic effects (liver
enlargement, decreased weight gain, and
decreased food consumption) at the
same dose as developmental effects
(increased incidences of 27 presacral
vertebrae and 27 presacral vertebrae
with 13th ribs). In the two-generation
reproduction study conducted with rats,
offspring toxicity was more severe (pup
mortality) than parental toxicity
(increased liver and adrenal weights) at
the same dose, indicating increased
qualitative susceptibility.
Specific information on the studies
received and the nature of the adverse
effects caused by etoxazole as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studiescan be found at https://
www.regulations.gov in document
‘‘Etoxazole; Human Health Risk
Assessment for Proposed Uses on Stone
Fruits, Cucumber, Tomato, and Mint,’’
pages 29-31 in docket ID number EPA–
HQ–OPP–2008–0554.
B. Toxicological Endpoints
For hazards that have a threshold
below which there is no appreciable
risk, a toxicological point of departure
(POD) is identified as the basis for
derivation of reference values for risk
assessment. The POD may be defined as
the highest dose at which no adverse
effects are observed (the NOAEL) in the
toxicology study identified as
appropriate for use in risk assessment.
However, if a NOAEL cannot be
determined, the lowest dose at which
adverse effects of concern are identified
(the LOAEL) or a Benchmark Dose
(BMD) approach is sometimes used for
risk assessment. Uncertainty/safety
factors (UFs) are used in conjunction
with the POD to take into account
uncertainties inherent in the
extrapolation from laboratory animal
data to humans and in the variations in
sensitivity among members of the
human population as well as other
unknowns. Safety is assessed for acute
and chronic dietary risks by comparing
aggregate food and water exposure to
the pesticide to the acute population
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
adjusted dose (aPAD) and chronic
population adjusted dose (cPAD). The
aPAD and cPAD are calculated by
dividing the POD by all applicable UFs.
Aggregate short-, intermediate-, and
chronic-term risks are evaluated by
comparing food, water, and residential
exposure to the POD to ensure that the
margin of exposure (MOE) called for by
the product of all applicable UFs is not
exceeded. This latter value is referred to
as the Level of Concern (LOC).
For non-threshold risks, the Agency
assumes that any amount of exposure
will lead to some degree of risk. Thus,
the Agency estimates risk in terms of the
probability of an occurrence of the
adverse effect greater than that expected
in a lifetime. For more information on
the general principles EPA uses in risk
characterization and a complete
description of the risk assessment
process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
A summary of the toxicological
endpoints for etoxazole used for human
risk assessment can be found at https://
www.regulations.gov in document
‘‘Etoxazole; Human Health Risk
Assessment for Proposed Uses on Stone
Fruits, Cucumber, Tomato, and Mint,’’
page 15 in docket ID number EPA–HQ–
OPP–2008–0554.
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to etoxazole, EPA considered
exposure under the petitioned-for
tolerances as well as all existing
etoxazole tolerances in (40 CFR
180.593). EPA assessed dietary
exposures from etoxazole in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1–day or single
exposure.
No such effects were identified in the
toxicological studies for etoxazole;
therefore, a quantitative acute dietary
exposure assessment is unnecessary.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
from the USDA 1994–1996 and 1998
CSFII. As to residue levels in food, EPA
used tolerance-level residues and
empirically determined (when
available) or DEEM default processing
factors. Additionally, EPA assumed 100
percent crop treated (PCT) for all
commodities covered by proposed or
existing tolerances.
iii. Cancer. Two mouse studies
showed no evidence of carcinogenicity
PO 00000
Frm 00014
Fmt 4700
Sfmt 4700
at the high dose. While benign
interstitial cell tumors in the testis and
pancreas benign islet cell adenomas
were observed in an unacceptable rat
carcinogenicity study, these effects were
not seen in a repeat study at higher
doses. Furthermore, special mechanistic
male rat studies resulted in no
observable changes in serum hormone
levels (estradiol, luteinizing hormone,
prolactin and testosterone) or
reproductive effects (interstitial cell
proliferation or spermatogenesis). EPA
determined that cancer risk concerns
due to long-term consumption of
etoxazole residues are adequately
addressed by the chronic dietary
exposure analysis; therefore, etoxazole
was classified as ‘‘not likely to be
carcinogenic to humans,’’ and a
quantitative exposure assessment to
evaluate cancer risk is unnecessary.
iv. Anticipated residue and PCT
information. EPA did not use
anticipated residue or PCT information
in the dietary assessment for etoxazole.
Tolerance level residues and 100 PCT
were assumed for all food commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for etoxazole in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of etoxazole.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www.epa.gov/oppefed1/models/
water/index.htm.
Based on the First Index Reservoir
Screening Tool (FIRST) model for
surface water, and Screening
Concentration in Ground Water (SCIGROW) model for ground water, the
estimated drinking water concentrations
(EDWCs) of etoxazole and its major
metabolites (R-8 and R-13) for surface
water are estimated to be 15.73 parts per
billion (ppb) for acute exposures and
4.761 ppb for chronic exposures. For
ground water, the estimated drinking
water concentration is estimated to be
0.746 ppb.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For
chronic dietary risk assessment, the
water concentration of value 4.761 ppb
was used to assess the contribution to
drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets). Etoxazole
E:\FR\FM\27MYR1.SGM
27MYR1
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
is not registered for any specific use
patterns that would result in residential
exposure.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found etoxazole to share
a common mechanism of toxicity with
any other substances, and etoxazole
does not appear to produce a toxic
metabolite produced by other
substances. For the purposes of this
tolerance action, therefore, EPA has
assumed that etoxazole does not have a
common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
PWALKER on PROD1PC71 with RULES
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(c) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA safety factor (SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
The toxicology data for etoxazole
provides no indication of increased
susceptibility, as compared to adults, of
rat and rabbit fetuses to in utero
exposure in developmental studies. In a
rat reproduction study, offspring
toxicity was more severe (pup mortality)
than parental toxicity (increased liver
and adrenal weights) at the same dose;
thereby indicating increased qualitative
susceptibility. Based on the above
concerns, a Degree of Concern Analysis
was performed by EPA, which
concluded that concern is low since:
i. The effects in pups are wellcharacterized with a clear NOAEL;
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
ii. The pup effects occur at the same
dose as parental toxicity; and
iii. The doses selected for various risk
assessment scenarios are lower than the
doses that caused offspring toxicity.
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1X. That decision is
based on the following findings:
i. The toxicity database for etoxazole
is complete except for acute and
subchronic neurotoxicity and
immunotoxicity studies. Recent changes
to 40 CFR 180.158 make acute and
subchronic neurotoxicity testing
(OPPTS Guideline 870.6200), and
immunotoxicity testing (OPPTS
Guideline 870.7800) required for
pesticide registration. Because these
testing requirements went into effect
shortly before the tolerance petition was
submitted, these studies are not yet
available for etoxazole. However, the
available data for etoxazole do not show
potential for immunotoxicity. Further,
there is no evidence of neurotoxicity in
any study in the toxicity database for
etoxazole. Therefore, EPA does not
believe that conducting neurotoxicity
and immunotoxicity studies will result
in a NOAEL lower than the NOAEL of
4.62 milligrams/kilograms/day already
established for etoxazole. Consequently,
an additional database uncertainty
factor does not need to be applied.
ii. There is no indication that
etoxazole is a neurotoxic chemical and
there is no need for a developmental
neurotoxicity study or additional
Uncertainity Factors (UFs) to account
for neurotoxicity.
iii. Although there is qualitative
evidence of increased susceptibility of
offspring (pup mortality) compared to
less severe parental effects (increased
liver and adrenal weights) at the same
dose in the rat multi–generation
reproduction study, the Agency did not
identify any residual uncertainties after
establishing toxicity endpoints and
traditional UFs (10X for interspecies
variation and 10X for intraspecies
variation) to be used in the risk
assessment. Therefore, there are no
residual concerns regarding
developmental effects in the young.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed based on 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to etoxazole in
drinking water. These assessments will
not underestimate the exposure and
risks posed by etoxazole.
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
25159
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic pesticide exposures are safe by
comparing aggregate exposure estimates
to the aPAD and cPAD. The aPAD and
cPAD represent the highest safe
exposures, taking into account all
appropriate SFs. EPA calculates the
aPAD and cPAD by dividing the POD by
all applicable UFs. For linear cancer
risks, EPA calculates the probability of
additional cancer cases given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the POD to
ensure that the MOE called for by the
product of all applicable UFs is not
exceeded.
1. Acute risk. An acute aggregate risk
assessment takes into account exposure
estimates from acute dietary
consumption of food and drinking
water. No adverse effect resulting from
a single-oral exposure was identified
and no acute dietary endpoint was
selected. Therefore, etoxazole is not
expected to pose an acute risk.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to etoxazole from
food and water will utilize 10% of the
cPAD for children 1-2 years old, the
population group receiving the greatest
exposure. There are no residential uses
for etoxazole to consider.
3. Short-, and intermediate-term risk.
Short-, and intermediate-term aggregate
exposure takes into account short-, and
intermediate-term residential exposure
plus chronic exposure to food and water
(considered to be a background
exposure level).
Etoxazole is not registered for any use
patterns that would result in residential
exposure. Therefore, the short-, and
intermediate-term aggregate risk is the
sum of the risk from exposure to
etoxazole through food and water and
will not be greater than the chronic
aggregate risk.
4. Aggregate cancer risk for U.S.
population. As discussed in Unit
III.C.1.iii., EPA has classified etoxazole
as ‘‘not likely to be carcinogenic to
humans,’’ and it is not expected to pose
a cancer risk to humans.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to etoxazole
residues.
E:\FR\FM\27MYR1.SGM
27MYR1
25160
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodologies
(gas chromatography/nitrogenphosphorus detection (GC/NPD) and gas
chromatography/mass selective
detection (GC/MSD) methods) are
available to enforce the tolerance
expression. The methods may be
requested from: Chief, Analytical
Chemistry Branch, Environmental
Science Center, 701 Mapes Rd., Ft.
Meade, MD 20755–5350; telephone
number: (410) 305–2905; e-mail address:
residuemethods@epa.gov.
B. International Residue Limits
Currently, there are no Codex,
Canadian, or Mexican maximum residue
limits (MRLs) established for residues of
etoxazole in or on the subject
commodities.
C. Response to Comments
EPA received one comment to the
Notice of Filing that made a general
objection to the presence of any
pesticide residues on crops and stated
that EPA should set no pesticide
tolerance greater than zero. The Agency
understands the commenter’s concerns
and recognizes that some individuals
believe that pesticides should be banned
completely. However, the existing legal
framework provided by section 408 of
FFDCA states that tolerances greater
than zero may be set when persons
seeking such tolerances or exemptions
have demonstrated that the pesticide
meets the safety standard imposed by
that statute. This citizen’s comment
appears to be directed at the underlying
statute and not EPA’s implementation of
it; the citizen has made no contention
that EPA has acted in violation of the
statutory framework.
PWALKER on PROD1PC71 with RULES
D. Revisions to Petitioned-For
Tolerances
Based upon review of the data
supporting the petition, EPA revised
tolerances for certain proposed
commodities, as follows: Plum from
0.12 ppm to 0.15 ppm; plum, prune,
dried from 0.40 ppm to 0.30 ppm; and
tomato from 0.25 ppm to 0.20 ppm. EPA
revised the tolerance levels based on
analysis of the residue field trial data
using the Agency’s Tolerance
Spreadsheet in accordance with the
Agency’s Guidance for Setting Pesticide
Tolerances Based on Field Trial Data.
V. Conclusion
Therefore, tolerances are established
for residues of etoxazole, 2-(2,6difluorophenyl)-4-[4-(1,1dimethylethyl)-2-ethoxyphenyl]-4,5-
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
dihydrooxazole, in or on fruit, stone,
group 12, except plum at 1.0 ppm; plum
at 0.15 ppm; plum, prune, dried at 0.30
ppm; cucumber at 0.02 ppm; tomato at
0.20 ppm; spearmint, tops at 10 ppm;
peppermint, tops at 10 ppm; spearmint,
oil at 20 ppm; and peppermint, oil at 20
ppm. This regulation also deletes the
existing tolerance in or on cherry at 1.0
ppm, as it is superseded by inclusion in
fruit, stone, group 12.
VI. Statutory and Executive Order
Reviews
This final rule establishes tolerances
under section 408(d) of FFDCA in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled Regulatory
Planning and Review (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
entitled Actions Concerning Regulations
That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled Protection of Children from
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Public Law 104–4).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
VII. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: May 15, 2009.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
■
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Section 180.593 is amended in
paragraph (a), by removing the
commodity ‘‘Cherry’’ and by
alphabetically adding the following
commodities to the table to read as
follows:
■
§ 180.593 Etoxazole; tolerances for
residues.
(a) General. * * *
E:\FR\FM\27MYR1.SGM
27MYR1
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Rules and Regulations
Commodity
Parts per million
*
*
*
Cucumber .......................
*
*
*
Fruit, stone, group 12,
except plum .................
*
*
*
Peppermint, oil ................
Peppermint, tops ............
*
*
*
Plum ................................
Plum, prune, dried ..........
*
*
*
Spearmint, oil ..................
Spearmint, tops ..............
*
*
*
Tomato ............................
*
*
*
*
*
*
*
*
*
*
*
*
*
0.02
1.0
20
10
*
*
0.15
0.30
*
*
20
10
*
*
*
*
0.20
I. Statutory Authority
*
[FR Doc. E9–12292 Filed 5–26–09; 8:45 am]
BILLING CODE 6560–50–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
45 CFR Part 286
RIN 0970–AC40
Temporary Assistance for Needy
Families (TANF) Carry-Over Funds
Administration for Children
and Families (ACF), Department of
Health and Human Services (HHS).
ACTION: Interim final rule.
SUMMARY: This rule implements the
statutory change to section 404(e) of the
Social Security Act (42 U.S.C. 604(e)) as
enacted by the American Recovery and
Reinvestment Act of 2009 (Pub. L. 111–
5). This change allows States, Tribes
and Territories to use Temporary
Assistance for Needy Families (TANF)
program funds carried over from a prior
year for any allowable TANF benefit,
service or activity. Previously these
funds could be used only to provide
assistance. This interim final rule
applies to States, local governments,
and Tribes that administer the TANF
program.
Effective Date: May 27, 2009.
Comment Date: Comments are due on
or before July 27, 2009.
ADDRESSES: You may mail or handdeliver comments regarding this interim
rule to the Administration for Children
and Families, Office of Family
Assistance, 370 L’Enfant Promenade,
SW., 5th floor, Washington, DC 20447.
You also may transmit comments
electronically via the Internet at:
PWALKER on PROD1PC71 with RULES
VerDate Nov<24>2008
16:09 May 26, 2009
Jkt 217001
Section 417 of the Social Security Act
(42 U.S.C. 617) limits the authority of
the Federal government to regulate State
conduct or enforce the TANF provisions
of the Social Security Act, except as
expressly provided. We have interpreted
this provision to allow us to regulate
where Congress has charged HHS with
enforcing certain TANF provisions by
assessing penalties. Because the
improper use of Federal TANF carryover funds can result in a financial
penalty pursuant to 42 U.S.C. 609(a)(1),
we have the authority to regulate in this
instance.
Justification for Interim Final Rule
AGENCY:
DATES:
https://www.regulations.gov. You may
download an electronic version of this
rule at: https://www.regulations.gov.
All comments received, including any
personal information provided, will be
available for public inspection Monday
through Friday, 8:30 a.m. to 5 p.m., at
901 D St., SW., 5th Floor, Washington
DC.
FOR FURTHER INFORMATION CONTACT:
Robert Shelbourne, Director, Division of
State TANF Policy and Acting Director,
Division of Tribal TANF Management,
Office of Family Assistance, ACF, at
(202) 401–5150.
SUPPLEMENTARY INFORMATION:
The Administrative Procedures Act
requirements under 5 U.S.C. 553 for
notice of proposed rulemaking do not
apply to rules when the agency finds
good cause that notice is impracticable,
unnecessary, or contrary to the public
interest (5 U.S.C. 553(b)). We find
proposed rulemaking unnecessary
because the policy was effective upon
enactment and this regulatory action
merely updates program regulations to
reflect current law and avoid any
unnecessary confusion on the part of
States and Tribes. The change made to
the TANF program by the Recovery Act
on the use of carry-over funds was
intended to provide increased flexibility
immediately to States and Tribes to
support work and families especially
during this difficult economic period. If
this regulation were delayed, States and
Tribes might be hesitant to take
advantage of the flexibility afforded by
the statutory change because of the
conflict with the regulation, and any
confusion resulting from that conflict.
For the same reason given above, we
also find good cause for waiving the
Administrative Procedures Act
requirement under 5 U.S.C. 553(d)
which provides that a rule generally
may not become effective less than 30
days after it is published in the Federal
PO 00000
Frm 00017
Fmt 4700
Sfmt 4700
25161
Register. Since the statute was effective
upon enactment and because this
regulation merely updates the
regulations to reflect the current law,
this rule is effective upon publication.
II. American Recovery and
Reinvestment Act of 2009
On February 17, 2009, the President
signed the American Recovery and
Reinvestment Act of 2009 (Pub. L. 111–
5), which included a provision to lift the
restriction on unspent Federal TANF
funds reserved or ‘‘carried over’’ into a
succeeding fiscal year. Prior to Public
Law 111–5, carry-over funds could only
be used to provide assistance (i.e.,
ongoing basic needs payments, and
supportive services such as
transportation and child care to families
who are not employed). Section 2103 of
Division B of Public Law 111–5 amends
section 404(e) of the Social Security Act
(Act) by allowing States, District of
Columbia, the Territories and Tribes to
use the carry-over funds for any
allowable TANF benefit, service, or
activity (such as job skills training or retraining activities, employment
counseling services, parental counseling
services, teen pregnancy prevention
activities, services for victims of
domestic violence, after-school
programs)—and not just assistance.
Thus, the policy reflected in this
interim final rule is effective
immediately and applies to all Federal
TANF funds carried over into fiscal year
2009 as well as to all future Federal
TANF funds carried over into a
subsequent year.
Herein after and as defined in section
419(5) of the Social Security Act, we
will use ‘‘States’’ to mean the 50 States
of the United States, the District of
Columbia, the Commonwealth of Puerto
Rico, the United States Virgin Islands,
Guam, and American Samoa. (However,
American Samoa has chosen not to
participate in the TANF program.)
III. Regulatory Provisions
As discussed below, section 2103 of
Public Law 111–5 requires a change in
the Tribal TANF regulation at 45 CFR
286.60. The TANF regulations at 45 CFR
Part 263, applicable to States and
Territories, require no change.
Part 286—Tribal TANF Provisions
Section 286.60: Must Tribes obligate all
Tribal Family Assistance Grant funds by
the end of the fiscal year in which they
are awarded?
Under prior law, section 404(e) of the
Act, entitled ‘‘Authority to Reserve
Certain Amounts for Assistance,’’
allowed States and Indian Tribes
E:\FR\FM\27MYR1.SGM
27MYR1
Agencies
[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Rules and Regulations]
[Pages 25156-25161]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12292]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2008-0554; FRL-8413-5]
Etoxazole; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
etoxazole in or on stone fruit; plum; prune; spearmint tops and oil;
peppermint tops and oil; tomato; and cucumber. This regulation also
deletes the existing cherry tolerance, as it will be superseded by
inclusion in the stone fruit crop group. The Interregional Research
Project Number 4 (IR-4) requested these tolerances under the Federal
Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective May 27, 2009. Objections and
requests for hearings must be received on or before July 27, 2009, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2008-0554. All documents in the
docket are listed in the docket index available at https://www.regulations.gov. Although listed in the index, some information is
not publicly available, e.g., Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
Internet and will be publicly available only in hard copy form.
Publicly available docket materials are available in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The Docket
Facility is open from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket Facility telephone number is (703)
305-5805.
FOR FURTHER INFORMATION CONTACT: Laura Nollen, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number: (703) 305-7390; e-mail address: nollen.laura@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to those
engaged in the following activities:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
This listing is not intended to be exhaustive, but rather to
provide a guide for readers regarding entities likely to be affected by
this action. Other types of entities not listed in this unit could also
be affected. The North American Industrial Classification System
(NAICS) codes have been provided to assist you and others in
determining whether this action might apply to certain entities. If you
have any questions regarding the applicability of this action to a
particular entity, consult the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies of this Document?
In addition to accessing electronically available documents at
https://www.regulations.gov, you may access this Federal Register
document electronically through the EPA Internet under the ``Federal
Register'' listings at https://www.epa.gov/fedrgstr. You may also access
a frequently updated electronic version of EPA's tolerance regulations
at 40 CFR part 180 through the Government Printing Office's e-CFR cite
at https://www.gpoaccess.gov/ecfr.
[[Page 25157]]
C. Can I File an Objection or Hearing Request?
Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2008-0554 in the subject line on the first
page of your submission. All requests must be in writing, and must be
mailed or delivered to the Hearing Clerk as required by 40 CFR part 178
on or before July 27, 2009.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice. Submit this copy, identified by docket ID number
EPA-HQ-OPP-2008-0554, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
II. Petition for Tolerance
In the Federal Register of August 13, 2008 (73 FR 47186) (FRL-8375-
8), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
8E7347) by IR-4, Rutgers, The State University of New Jersey, 500
College Road East, Suite 201 W., Princeton, NJ 08540. The petition
requested that 40 CFR 180.593 be amended by establishing tolerances for
residues of the insecticide etoxazole, 2-(2,6-difluorophenyl)-4-[4-
(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydrooxazole, in or on fruit,
stone, group 12, except plum at 1.0 parts per million (ppm); plum at
0.12 ppm; plum, prune, dried at 0.4 ppm; cucumber at 0.02 ppm; tomato
at 0.25; spearmint, tops at 10 ppm; peppermint, tops at 10 ppm;
peppermint, oil at 20 ppm; and spearmint, oil at 20 ppm. The petition
additionally requested to delete the tolerance for residues of
etoxazole in or on the food commodity cherry at 1.0 ppm. That notice
referenced a summary of the petition prepared on behalf of IR-4 by
Valent U.S.A. Corporation, the registrant, which is available to the
public in the docket, https://www.regulations.gov. Comments were
received on the notice of filing. EPA's response to these comments is
discussed in Unit IV.C.
Based upon review of the data supporting the petition, EPA has
revised the proposed tolerance levels for plum; plum, prune, dried; and
tomato. The reason for these changes is explained in Unit IV.D.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with section 408(b)(2)(D) of FFDCA, and the factors
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action. EPA has sufficient data to assess the hazards of and to
make a determination on aggregate exposure for the petitioned-for
tolerances for residues of etoxazole on fruit, stone, group 12, except
plum at 1.0 ppm; plum at 0.15 ppm; plum, prune, dried at 0.30 ppm;
cucumber at 0.02 ppm; tomato at 0.20; spearmint, tops at 10 ppm;
peppermint, tops at 10 ppm; peppermint, oil at 20 ppm; and spearmint,
oil at 20 ppm. EPA's assessment of exposures and risks associated with
establishing tolerances follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The existing etoxazole data indicate that it possess low acute
toxicity via all routes of exposure. It is not an eye or dermal
irritant or a dermal sensitizer. No toxicity was seen at the limit dose
in a 28-day dermal toxicity study in rats.
The liver is the main target organ in mice, rats and dogs. In a 90-
day toxicity study in dogs, increased liver weights and centrilobular
hepatocellular swelling in the liver were observed. Similar effects
were observed in a chronic toxicity study in dogs at similar doses,
indicating that systemic effects (mainly liver effects) occur at
similar dose levels following short- through long-term exposure without
increasing in severity. In a 90-day toxicity study in mice,
hepatotoxicity (increased relative liver weight, liver enlargement, and
centrilobular hepatocellular swelling) was observed at high doses.
Similar effects were observed at the high dose in a mouse
carcinogenicity study. Subchronic and chronic toxicity studies in rats
produced similar effects (increased liver weights, centrilobular
hepatocellular swelling, etc.) to those seen in mice and dogs. In
addition, slight increases in thyroid weights and incisors were
observed in subchronic and chronic toxicity studies in rats at high
doses and at terminal stages of the study. Toxicity was not observed at
the highest dose tested (HDT) in another carcinogenicity study in mice.
There is no evidence of immunotoxicity or neurotoxicity in any of the
submitted studies.
Two studies in mice showed no evidence of carcinogenicity up to the
HDT. In a rat carcinogenicity study, which was deemed unacceptable due
to inadequate dosing, benign interstitial cell tumors (testis) and
pancreas benign islet cell adenomas were observed (in females) at the
high dose. These effects were not observed in an acceptable
carcinogenicity study in rats at higher doses. In special mechanistic
male rat studies there were no observable
[[Page 25158]]
changes in serum hormone levels (estradiol, luteinizing hormone (LH),
prolactin and testosterone) or reproductive effects (interstitial cell
proliferation or spermatogenesis) noted. EPA classified etoxazole as
``not likely to be carcinogenic to humans.'' Etoxazole is not
mutagenic.
The toxicology data for etoxazole provides no indication of
increased susceptibility, as compared to adults, of rat and rabbit
fetuses to in utero exposure in developmental studies. The rabbit
developmental toxicity study included maternal toxic effects (liver
enlargement, decreased weight gain, and decreased food consumption) at
the same dose as developmental effects (increased incidences of 27
presacral vertebrae and 27 presacral vertebrae with 13th ribs). In the
two-generation reproduction study conducted with rats, offspring
toxicity was more severe (pup mortality) than parental toxicity
(increased liver and adrenal weights) at the same dose, indicating
increased qualitative susceptibility.
Specific information on the studies received and the nature of the
adverse effects caused by etoxazole as well as the no-observed-adverse-
effect-level (NOAEL) and the lowest-observed-adverse-effect-level
(LOAEL) from the toxicity studiescan be found at https://www.regulations.gov in document ``Etoxazole; Human Health Risk
Assessment for Proposed Uses on Stone Fruits, Cucumber, Tomato, and
Mint,'' pages 29-31 in docket ID number EPA-HQ-OPP-2008-0554.
B. Toxicological Endpoints
For hazards that have a threshold below which there is no
appreciable risk, a toxicological point of departure (POD) is
identified as the basis for derivation of reference values for risk
assessment. The POD may be defined as the highest dose at which no
adverse effects are observed (the NOAEL) in the toxicology study
identified as appropriate for use in risk assessment. However, if a
NOAEL cannot be determined, the lowest dose at which adverse effects of
concern are identified (the LOAEL) or a Benchmark Dose (BMD) approach
is sometimes used for risk assessment. Uncertainty/safety factors (UFs)
are used in conjunction with the POD to take into account uncertainties
inherent in the extrapolation from laboratory animal data to humans and
in the variations in sensitivity among members of the human population
as well as other unknowns. Safety is assessed for acute and chronic
dietary risks by comparing aggregate food and water exposure to the
pesticide to the acute population adjusted dose (aPAD) and chronic
population adjusted dose (cPAD). The aPAD and cPAD are calculated by
dividing the POD by all applicable UFs. Aggregate short-, intermediate-
, and chronic-term risks are evaluated by comparing food, water, and
residential exposure to the POD to ensure that the margin of exposure
(MOE) called for by the product of all applicable UFs is not exceeded.
This latter value is referred to as the Level of Concern (LOC).
For non-threshold risks, the Agency assumes that any amount of
exposure will lead to some degree of risk. Thus, the Agency estimates
risk in terms of the probability of an occurrence of the adverse effect
greater than that expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www.epa.gov/pesticides/factsheets/riskassess.htm.
A summary of the toxicological endpoints for etoxazole used for
human risk assessment can be found at https://www.regulations.gov in
document ``Etoxazole; Human Health Risk Assessment for Proposed Uses on
Stone Fruits, Cucumber, Tomato, and Mint,'' page 15 in docket ID number
EPA-HQ-OPP-2008-0554.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to etoxazole, EPA considered exposure under the petitioned-for
tolerances as well as all existing etoxazole tolerances in (40 CFR
180.593). EPA assessed dietary exposures from etoxazole in food as
follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
No such effects were identified in the toxicological studies for
etoxazole; therefore, a quantitative acute dietary exposure assessment
is unnecessary.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 1994-1996
and 1998 CSFII. As to residue levels in food, EPA used tolerance-level
residues and empirically determined (when available) or DEEM default
processing factors. Additionally, EPA assumed 100 percent crop treated
(PCT) for all commodities covered by proposed or existing tolerances.
iii. Cancer. Two mouse studies showed no evidence of
carcinogenicity at the high dose. While benign interstitial cell tumors
in the testis and pancreas benign islet cell adenomas were observed in
an unacceptable rat carcinogenicity study, these effects were not seen
in a repeat study at higher doses. Furthermore, special mechanistic
male rat studies resulted in no observable changes in serum hormone
levels (estradiol, luteinizing hormone, prolactin and testosterone) or
reproductive effects (interstitial cell proliferation or
spermatogenesis). EPA determined that cancer risk concerns due to long-
term consumption of etoxazole residues are adequately addressed by the
chronic dietary exposure analysis; therefore, etoxazole was classified
as ``not likely to be carcinogenic to humans,'' and a quantitative
exposure assessment to evaluate cancer risk is unnecessary.
iv. Anticipated residue and PCT information. EPA did not use
anticipated residue or PCT information in the dietary assessment for
etoxazole. Tolerance level residues and 100 PCT were assumed for all
food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for etoxazole in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of etoxazole. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www.epa.gov/oppefed1/models/water/index.htm.
Based on the First Index Reservoir Screening Tool (FIRST) model for
surface water, and Screening Concentration in Ground Water (SCI-GROW)
model for ground water, the estimated drinking water concentrations
(EDWCs) of etoxazole and its major metabolites (R-8 and R-13) for
surface water are estimated to be 15.73 parts per billion (ppb) for
acute exposures and 4.761 ppb for chronic exposures. For ground water,
the estimated drinking water concentration is estimated to be 0.746
ppb.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For chronic dietary risk
assessment, the water concentration of value 4.761 ppb was used to
assess the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Etoxazole
[[Page 25159]]
is not registered for any specific use patterns that would result in
residential exposure.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found etoxazole to share a common mechanism of toxicity
with any other substances, and etoxazole does not appear to produce a
toxic metabolite produced by other substances. For the purposes of this
tolerance action, therefore, EPA has assumed that etoxazole does not
have a common mechanism of toxicity with other substances. For
information regarding EPA's efforts to determine which chemicals have a
common mechanism of toxicity and to evaluate the cumulative effects of
such chemicals, see EPA's website at https://www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(c) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA safety
factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. The toxicology data for
etoxazole provides no indication of increased susceptibility, as
compared to adults, of rat and rabbit fetuses to in utero exposure in
developmental studies. In a rat reproduction study, offspring toxicity
was more severe (pup mortality) than parental toxicity (increased liver
and adrenal weights) at the same dose; thereby indicating increased
qualitative susceptibility. Based on the above concerns, a Degree of
Concern Analysis was performed by EPA, which concluded that concern is
low since:
i. The effects in pups are well-characterized with a clear NOAEL;
ii. The pup effects occur at the same dose as parental toxicity;
and
iii. The doses selected for various risk assessment scenarios are
lower than the doses that caused offspring toxicity.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for etoxazole is complete except for acute
and subchronic neurotoxicity and immunotoxicity studies. Recent changes
to 40 CFR 180.158 make acute and subchronic neurotoxicity testing
(OPPTS Guideline 870.6200), and immunotoxicity testing (OPPTS Guideline
870.7800) required for pesticide registration. Because these testing
requirements went into effect shortly before the tolerance petition was
submitted, these studies are not yet available for etoxazole. However,
the available data for etoxazole do not show potential for
immunotoxicity. Further, there is no evidence of neurotoxicity in any
study in the toxicity database for etoxazole. Therefore, EPA does not
believe that conducting neurotoxicity and immunotoxicity studies will
result in a NOAEL lower than the NOAEL of 4.62 milligrams/kilograms/day
already established for etoxazole. Consequently, an additional database
uncertainty factor does not need to be applied.
ii. There is no indication that etoxazole is a neurotoxic chemical
and there is no need for a developmental neurotoxicity study or
additional Uncertainity Factors (UFs) to account for neurotoxicity.
iii. Although there is qualitative evidence of increased
susceptibility of offspring (pup mortality) compared to less severe
parental effects (increased liver and adrenal weights) at the same dose
in the rat multi-generation reproduction study, the Agency did not
identify any residual uncertainties after establishing toxicity
endpoints and traditional UFs (10X for interspecies variation and 10X
for intraspecies variation) to be used in the risk assessment.
Therefore, there are no residual concerns regarding developmental
effects in the young.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to etoxazole in drinking water. These assessments
will not underestimate the exposure and risks posed by etoxazole.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic pesticide exposures are
safe by comparing aggregate exposure estimates to the aPAD and cPAD.
The aPAD and cPAD represent the highest safe exposures, taking into
account all appropriate SFs. EPA calculates the aPAD and cPAD by
dividing the POD by all applicable UFs. For linear cancer risks, EPA
calculates the probability of additional cancer cases given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the POD to ensure that the MOE called for
by the product of all applicable UFs is not exceeded.
1. Acute risk. An acute aggregate risk assessment takes into
account exposure estimates from acute dietary consumption of food and
drinking water. No adverse effect resulting from a single-oral exposure
was identified and no acute dietary endpoint was selected. Therefore,
etoxazole is not expected to pose an acute risk.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
etoxazole from food and water will utilize 10% of the cPAD for children
1-2 years old, the population group receiving the greatest exposure.
There are no residential uses for etoxazole to consider.
3. Short-, and intermediate-term risk. Short-, and intermediate-
term aggregate exposure takes into account short-, and intermediate-
term residential exposure plus chronic exposure to food and water
(considered to be a background exposure level).
Etoxazole is not registered for any use patterns that would result
in residential exposure. Therefore, the short-, and intermediate-term
aggregate risk is the sum of the risk from exposure to etoxazole
through food and water and will not be greater than the chronic
aggregate risk.
4. Aggregate cancer risk for U.S. population. As discussed in Unit
III.C.1.iii., EPA has classified etoxazole as ``not likely to be
carcinogenic to humans,'' and it is not expected to pose a cancer risk
to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to etoxazole residues.
[[Page 25160]]
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodologies (gas chromatography/nitrogen-
phosphorus detection (GC/NPD) and gas chromatography/mass selective
detection (GC/MSD) methods) are available to enforce the tolerance
expression. The methods may be requested from: Chief, Analytical
Chemistry Branch, Environmental Science Center, 701 Mapes Rd., Ft.
Meade, MD 20755-5350; telephone number: (410) 305-2905; e-mail address:
residuemethods@epa.gov.
B. International Residue Limits
Currently, there are no Codex, Canadian, or Mexican maximum residue
limits (MRLs) established for residues of etoxazole in or on the
subject commodities.
C. Response to Comments
EPA received one comment to the Notice of Filing that made a
general objection to the presence of any pesticide residues on crops
and stated that EPA should set no pesticide tolerance greater than
zero. The Agency understands the commenter's concerns and recognizes
that some individuals believe that pesticides should be banned
completely. However, the existing legal framework provided by section
408 of FFDCA states that tolerances greater than zero may be set when
persons seeking such tolerances or exemptions have demonstrated that
the pesticide meets the safety standard imposed by that statute. This
citizen's comment appears to be directed at the underlying statute and
not EPA's implementation of it; the citizen has made no contention that
EPA has acted in violation of the statutory framework.
D. Revisions to Petitioned-For Tolerances
Based upon review of the data supporting the petition, EPA revised
tolerances for certain proposed commodities, as follows: Plum from 0.12
ppm to 0.15 ppm; plum, prune, dried from 0.40 ppm to 0.30 ppm; and
tomato from 0.25 ppm to 0.20 ppm. EPA revised the tolerance levels
based on analysis of the residue field trial data using the Agency's
Tolerance Spreadsheet in accordance with the Agency's Guidance for
Setting Pesticide Tolerances Based on Field Trial Data.
V. Conclusion
Therefore, tolerances are established for residues of etoxazole, 2-
(2,6-difluorophenyl)-4-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-
dihydrooxazole, in or on fruit, stone, group 12, except plum at 1.0
ppm; plum at 0.15 ppm; plum, prune, dried at 0.30 ppm; cucumber at 0.02
ppm; tomato at 0.20 ppm; spearmint, tops at 10 ppm; peppermint, tops at
10 ppm; spearmint, oil at 20 ppm; and peppermint, oil at 20 ppm. This
regulation also deletes the existing tolerance in or on cherry at 1.0
ppm, as it is superseded by inclusion in fruit, stone, group 12.
VI. Statutory and Executive Order Reviews
This final rule establishes tolerances under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, entitled Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997). This final rule does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any
special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the tolerance in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled Federalism (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
Consultation and Coordination with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (Public Law 104-4).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
VII. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: May 15, 2009.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
0
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Section 180.593 is amended in paragraph (a), by removing the
commodity ``Cherry'' and by alphabetically adding the following
commodities to the table to read as follows:
Sec. 180.593 Etoxazole; tolerances for residues.
(a) General. * * *
[[Page 25161]]
------------------------------------------------------------------------
Commodity Parts per million
------------------------------------------------------------------------
* * * * *
Cucumber............................................. 0.02
* * * * *
Fruit, stone, group 12, except plum.................. 1.0
* * * * *
Peppermint, oil...................................... 20
Peppermint, tops..................................... 10
* * * * *
Plum................................................. 0.15
Plum, prune, dried................................... 0.30
* * * * *
Spearmint, oil....................................... 20
Spearmint, tops...................................... 10
* * * * *
Tomato............................................... 0.20
* * * * *
------------------------------------------------------------------------
* * * * *
[FR Doc. E9-12292 Filed 5-26-09; 8:45 am]
BILLING CODE 6560-50-S